Novo Nordisk A/S (NVO) Stock Is Higher By 2.11% This Week: Buy, Hold, or Sell?

Novo Nordisk A/S (NVO) stock is higher by 32.90% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NVO stock a score of 77 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 95. NVO's rank also includes a long-term technical score of 95. The fundamental score for NVO is 40. In addition to the average rating from Wall Street analysts, NVO stock has a mean target price of $132.30. This means analysts expect the stock to increase 21.85% over the next 12 months.

NVO has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on NVO!

See Full NVO Report

What's Happening with NVO Stock Today

Novo Nordisk A/S (NVO) stock is up 0.69% while the S&P 500 has fallen -2.13% as of 10:15 AM on Tuesday, May 24. NVO is higher by $0.74 from the previous closing price of $107.84 on volume of 65,568 shares. Over the past year the S&P 500 is lower by -7.34% while NVO is higher by 32.90%. NVO earned $3.08 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 35.17. Click Here to get the full Stock Report for Novo Nordisk A/S stock.